BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26730710)

  • 1. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.
    Firnhaber C; Goeieman B; Faesen M; Levin S; Williams S; Rameotshela S; Swarts A; Michelow P; Omar T; Williamson AL; Allan B; Schnippel K; Smith JS
    PLoS One; 2016; 11(1):e0144905. PubMed ID: 26730710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
    Poomtavorn Y; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
    Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of cervical neoplasia in HIV-infected women in India.
    Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
    AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
    Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
    PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
    Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
    Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
    JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
    Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.
    Segondy M; Kelly H; Magooa MP; Djigma F; Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Michelow P; Doutre S; Clavero O; Chikandiwa A; Sawadogo B; Didelot MN; Costes V; Méda N; Delany-Moretlwe S; Mayaud P
    Br J Cancer; 2016 Aug; 115(4):425-30. PubMed ID: 27434037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.
    Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A
    BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
    Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
    Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of OncoE6
    Ndizeye Z; Menon S; Van Geertruyden JP; Sauvaget C; Jacquemyn Y; Bogers JP; Benoy I; Vanden Broeck D
    BMJ Open; 2019 Sep; 9(9):e029088. PubMed ID: 31494606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.